Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury: Randomized Comparative Study

NCT07875322 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07875322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury: Randomized Comparative Study
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
November 1, 2028
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-tuberculous drug reaction, protection from liver injury